Connecting you to content on EBSCOhost

Works matching AU Zopf, Christopher J.

Results: 2

1

A phase 1, dose-escalation study of PF-06664178, an anti-Trop-2/Aur0101 antibody-drug conjugate in patients with advanced or metastatic solid tumors.

Published in:

Investigational New Drugs, 2018, v. 36, n. 5, p. 836, doi. 10.1007/s10637-018-0560-6

By:

King, Gentry T.;
Eaton, Keith D.;
Beagle, Brandon R.;
Zopf, Christopher J.;
Wong, Gilbert Y.;
Krupka, Heike I.;
Hua, Steven Y.;
Messersmith, Wells A.;
El-Khoueiry, Anthony B.

Publication type:

Article

2

First‐in‐human, phase I study of PF‐06647263, an anti‐EFNA4 calicheamicin antibody–drug conjugate, in patients with advanced solid tumors.

Published in:

International Journal of Cancer, 2019, v. 145, n. 7, p. 1798, doi. 10.1002/ijc.32154

By:

Garrido‐Laguna, Ignacio;
Krop, Ian;
Burris, Howard A.;
Hamilton, Erika;
Braiteh, Fadi;
Weise, Amy M.;
Abu‐Khalaf, Maysa;
Werner, Theresa L.;
Pirie‐Shepherd, Steven;
Zopf, Christopher J.;
Lakshminarayanan, Mani;
Holland, Jaymes S.;
Baffa, Raffaele;
Hong, David S.

Publication type:

Article